Hemodynamic effects of iodixanol and iohexol during ventriculography in patients with compromised left ventricular function

Autor: Bergstra, A, van Dijk, RB, Brekke, O, Orozco, L, den Heijer, P, Crijns, HJGM

Publikováno v: Catheterization and Cardiovascular Interventions, 50(3), 314-321. Wiley

A crossover study was performed to compare the hemodynamic effects of the isoosmolar contrast agent iodixanol (Visipaque(R)) 320 mg I/ml to those of the low-osmolar iohexol (Omnipaque(R)) 350 mg I/ml. The main hypothesis was that iodixanol and iohexo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::ed2c634288536a27b7022102bc162a81
https://research.rug.nl/en/publications/03ee0175-1c7d-4c95-9582-009578ef3b47

Perceived barriers of heart failure nurses and cardiologists in using clinical decision support systems in the treatment of heart failure patients.

Autor: de Vries AE; Department of Cardiology, University Medical Centre Groningen, Hanzeplein 1, PO Box 30.001, 9700 RB Groningen, The Netherlands. a.e.de.vries@umcg.nl, van der Wal MH, Nieuwenhuis MM, de Jong RM, van Dijk RB, Jaarsma T, Hillege HL, Jorna RJ

Publikováno v: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2013 Apr 26; Vol. 13, pp. 54. Date of Electronic Publication: 2013 Apr 26.

Follow-up and treatment of an instable patient with heart failure using telemonitoring and a computerised disease management system: a case report.

Autor: de Vries AE; Department of Cardiology, University Medical Centre Groningen, University of Groningen, The Netherlands. a.e.de.vries@thorax.umcg.nl, van der Wal MH, Bedijn W, de Jong RM, van Dijk RB, Hillege HL, Jaarsma T

Publikováno v: European journal of cardiovascular nursing [Eur J Cardiovasc Nurs] 2012 Dec; Vol. 11 (4), pp. 432-8. Date of Electronic Publication: 2012 Apr 18.

C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.

Autor: Geluk CA; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, The Netherlands. Electronic address: c.a.geluk@thorax.umcg.nl., Post WJ; Department of Epidemiology, University Medical Center Groningen, University of Groningen, The Netherlands., Hillege HL; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, The Netherlands., Tio RA; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, The Netherlands., Tijssen JGP; Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands., van Dijk RB; Department of Cardiology, Martini Hospital Groningen, The Netherlands., Arnold Dijk W; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, The Netherlands., Bakker SJL; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, The Netherlands., de Jong PE; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, The Netherlands., van Gilst WH; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, The Netherlands; Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands., Zijlstra F; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, The Netherlands.

Publikováno v: Atherosclerosis [Atherosclerosis] 2008 Jan; Vol. 196 (1), pp. 372-382. Date of Electronic Publication: 2006 Dec 08.

Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure.

Autor: Smilde TD; Department of Cardiology, Thoraxcenter, University Medical Center Groningen, The Netherlands. t.d.j.smilde@thorax.azg.nl, Linssen GC, Gallemann D, Kuhn T, Machnig T, Mol PG, Hillege HL, Van Wijk LM, Van Dijk RB, Van Veldhuisen DJ

Publikováno v: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2005 Nov; Vol. 43 (11), pp. 507-16.